Detalhe da pesquisa
1.
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180219
2.
Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report.
Neurol Sci
; 42(Suppl 1): 25-28, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712907
3.
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
Mult Scler
; 26(12): 1519-1531, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31573386
4.
Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients.
Clin Immunol
; 181: 83-88, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28642148
5.
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 93(4): 448-450, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408003
6.
The use of the 25 Sprotte needle markedly reduces post-dural puncture headache in routine neurological practice.
Cephalalgia
; 36(2): 131-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25908221
7.
The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial.
BMC Neurol
; 16: 7, 2016 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26757728
8.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Mult Scler
; 20(9): 1265-8, 2014 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24515732
9.
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Neurol Sci
; 35(2): 307-16, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24374787
10.
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study.
J Neurol
; 271(1): 340-354, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715789
11.
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.
J Neurol
; 271(1): 24-31, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922069
12.
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy.
Neurol Sci
; 34(2): 197-203, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22407022
13.
Prevalence and significant determinants of post-traumatic stress disorder in a large sample of patients with multiple sclerosis.
J Clin Psychol Med Settings
; 20(2): 240-6, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23053829
14.
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study.
Neurol Ther
; 12(4): 1375-1383, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166677
15.
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study.
Mult Scler Relat Disord
; 70: 104474, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584654
16.
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.
J Neurol
; 270(10): 4687-4696, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405689
17.
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-γ and interleukin-4 response.
Mult Scler
; 18(10): 1484-92, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22562951
18.
sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients.
Mult Scler Relat Disord
; 67: 104176, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36126541
19.
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
Neurol Neuroimmunol Neuroinflamm
; 9(2)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046084
20.
Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice.
Mult Scler Relat Disord
; 54: 103090, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34182224